Today: 6 July 2026
Woolworths share price drops 2.3%: what to watch before WOW’s Feb. 25 results
20 February 2026
1 min read

Woolworths share price drops 2.3%: what to watch before WOW’s Feb. 25 results

Sydney, Feb 20, 2026, 17:59 AEDT — Market shut down for the day.

  • Woolworths shares finished Friday at A$31.23, down 2.3%, just off the session’s low.
  • Half-year results from the grocer are set for Feb. 25, marking a pivotal moment for both margins and guidance resets.
  • Australia’s major supermarkets still face ongoing questions about their pricing as reporting season approaches.

Woolworths Group Ltd dropped 2.3% on Friday, closing at A$31.23—a loss of 73 Australian cents from the previous session. Shares fluctuated between A$31.20 and A$31.85 throughout the day, with roughly 3.4 million shares traded.

After the week’s trading wraps up, the focus swings to Wednesday, Feb. 25. That’s when Woolworths will post its half-year results to the ASX—a six-month earnings readout that tends to shake up price forecasts in a hurry.

The date comes as regulators ramp up scrutiny on the sector compared to last year. ACCC Chair Gina Cass-Gottlieb, in a Feb. 19 speech, noted that ongoing court actions against Woolworths and Coles over allegedly misleading discount pricing are still before the Federal Court. “Accurate and meaningful pricing information is fundamental to effective competition,” Cass-Gottlieb said. ACCC

This week, Woolworths disclosed new specifics about its cost and energy usage. On Feb. 19, the retailer announced it now sources 100% of its electricity from renewables in both Australia and New Zealand, achieving its 2020-set target well ahead of the RE100 initiative’s 2030 deadline. “Every supermarket and distribution centre … has been running solely on renewable electricity,” said Simon Lowden, who oversees public affairs, communications and sustainability. Woolworths Group

The retailer is ramping up its loyalty-driven offers to attract shoppers watching their budgets. Woolworths plans to launch an Everyday Rewards cookware deal with Fissler, running from March 18 through July 7; shoppers earn credits based on spending, which they can swap for stainless-steel cookware. “We’re always looking at how we can give our customers more value,” said Robert Glenn, who heads collectibles at Woolworths. Woolworths Group

Not much relief from the wider market. The S&P/ASX 200 edged down 0.05% Friday, pulled lower by consumer staples dragging on the index.

Coles Group shares finished 1.6% lower at A$21.52, the company’s share price page showed. Investors tend to push Coles and Woolworths in the same direction, with both stocks frequently tracking each other when sentiment shifts on supermarkets.

Woolworths heads into next week’s results with three things in the spotlight: sales trends, cost headwinds, and management’s read on how hard promotions are biting as consumers hunt for deals. Investors will be quick to pick up on any signal about how discounting is squeezing margins.

But it’s a double-edged sword here. Should the company sound cautious, or point to rougher trading, the stock might keep sliding after Friday—especially with pricing still drawing legal and regulatory heat.

Shan Ahmed Khan is a senior markets reporter at TS2.tech, specializing in stocks, technology and macroeconomic trends. A graduate of the Lahore University of Management Sciences (LUMS), he previously worked in investment research and market analysis. His coverage helps readers understand the key developments influencing global financial markets and emerging industries.

Stock Market Today

  • Faeth Therapeutics (FTH) Gives Stock Options to Six New Hires Under Inducement Plan
    July 5, 2026, 11:31 PM EDT. Faeth Therapeutics (Nasdaq: FTH) handed out stock options for 180,350 shares to six new staffers under its 2026 Inducement Plan, in line with Nasdaq Listing Rule 5635(c)(4). The options carry exercise prices based on the closing prices on June 25 and June 29, 2026-$24.67 and $23.22 a share. Vesting starts after a year, with the rest vesting monthly for three years if employment continues. Faeth, a clinical-stage biotech working on cancer drugs, is pushing ahead with its main program, PIKTOR, in endometrial and breast cancer.
Uber stock: Tuesday test looms after Uber Eats targets $1 billion boost in Europe
Previous Story

Uber stock: Tuesday test looms after Uber Eats targets $1 billion boost in Europe

Opendoor stock jumps 17% premarket after Q4 results — what traders watch next for OPEN
Next Story

Opendoor stock jumps 17% premarket after Q4 results — what traders watch next for OPEN

Go toTop